Sorry, you need to enable JavaScript to visit this website.

BENEFIX® (nonacog alfa) Patient Counseling Information

17 PATIENT COUNSELING INFORMATION

  • Advise patients to read the FDA-approved patient labeling (Patient Information and Instructions for Use)
  • Allergic-type hypersensitivity reactions are possible. Inform patients of the early signs of hypersensitivity reactions [including hives (rash with itching), generalized urticaria, tightness of the chest, wheezing, hypotension] and anaphylaxis. Advise patients to discontinue use of the product and contact their physicians if these symptoms occur.
  • Advise patients to contact their physician or treatment facility for further treatment and/or assessment if they experience a lack of a clinical response to factor IX replacement therapy, as in some cases this may be a manifestation of an inhibitor.
Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No